AstraZeneca plc (AZN) Ordinary US$0.25
412.00p
(4.09%)
- Add to watchlist
- Create an alert
- This stock can be held in a
412.00p
(4.09%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
412.00p
(4.09%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
10,184.00p
10,561.52p
13,338.00p
£162.38 bn
10,062.00p
10,140.00p
9,461.00p
32.97
93.00p (0.93%) Previous:
93.00p
2,868,592
2.17%
150
Performance
| 1 week 1W | 2.23% | 1 year 1Y | 1.28% |
|---|---|---|---|
| 1 month 1M | 15.66% | 2 years 2Y | 9.11% |
| 3 months 3M | 22.6% | 3 years 3Y | 18.67% |
| 6 months 6M | 18.62% | 5 years 5Y | 37.16% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
| Year ending: | 31/12/2023 | 31/12/2022 |
|---|---|---|
| Revenue ($m) | 45,811.00 | 44,351.00 |
| Profit before tax ($m) | 6,899.00 | 2,501.00 |
| Adjusted EPS (¢): | 384.00 | 212.00 |
| P/E ratio | 34.70 | 66.50 |
| PEG | 0.40 | n/a |
| EPS growth (%) | 81.00 | 2,550.00 |
Values are quoted in the stock's local currency: US dollar
All fundamental dataRecent dividends paid or declared by AstraZeneca plc:
| Type | Ex-div date | Payment date | Amount |
|---|---|---|---|
| 1st interim | 08/08/2024 | 09/09/2024 | 100.00¢ |
| 2nd interim | 22/02/2024 | 25/03/2024 | 197.00¢ |
| 1st interim | 10/08/2023 | 11/09/2023 | 93.00¢ |
| 2nd interim | 23/02/2023 | 27/03/2023 | 197.00¢ |
| 1st interim | 11/08/2022 | 12/09/2022 | 93.00¢ |
This data is provided by Digital Look. HL accepts no responsibility for its accuracy and you should independently check data before making any investment decision.
Full dividend historyFive years' total annual AstraZeneca plc dividends:
| Financial year end |
Dividend yield |
Dividend cover |
Total dividend paid |
|---|---|---|---|
| 31/12/2023 | 2.20% | 1.32 | $2.90 |
| 31/12/2022 | 2.10% | 0.73 | $2.90 |
| 31/12/2021 | 2.60% | 0.03 | $2.87 |
| 31/12/2020 | 3.00% | 0.87 | $2.80 |
| 31/12/2019 | 2.90% | 0.37 | $2.80 |
All dividend data is calculated excluding any special dividends. Historical dividends may be adjusted to reflect any subsequent rights issues and corporate actions.
Full dividend historyReady to invest?
Important Documents
There are no documents available for this stock.
-
AstraZeneca's Tagrisso recommended for EU approval
18 November 2024 09:11
-
Sunday newspaper round-up: Kursk, AstraZeneca, BAE Systems
17 November 2024 18:14
-
Director dealings: AstraZeneca CEO ups stake
15 November 2024 16:11
-
Director/PDMR Shareholding
20 November 2024 16:00
-
Tagrisso recommended for EU approval - LAURA
18 November 2024 07:00
-
Director/PDMR Shareholding
15 November 2024 10:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.